The research findings were as follows: (1) plasma MIF levels were elevated in SCI patients compared to that of in normal controls; (2) MIF levels in plasma were related to SCI severity based on ASIA; (3) higher plasma MIF were related to elevated risk of DVT in the follow-up of 1 month, for each additional 1ng/mL of MIF, the DVT risk before and after adjustment was increased by 11% and 8%, respectively; (4) MIF plasma levels at admission may be significant in predicting DVT of SCI patients.
← all excerpts
Association between plasma macrophage migration inhibitor factor and deep vein thrombosis in patients with spinal cord injuries.
1
—
—